TritonPoint Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.47M Buy
3,728
+133
+4% +$136K 0.44% 56
2026
Q1
$3.31M Sell
3,595
-90
-2% -$91.2K 0.35% 71
2025
Q4
$3.96M Sell
3,685
-334
-8% -$319K 0.4% 61
2025
Q3
$3.07M Buy
4,019
+59
+1% +$43.9K 0.26% 93
2025
Q2
$3.09M Sell
3,960
-294
-7% -$228K 0.29% 87
2025
Q1
$3.51M Buy
4,254
+70
+2% +$58.2K 0.33% 79
2024
Q4
$3.23M Buy
4,184
+108
+3% +$89.4K 0.29% 87
2024
Q3
$3.58M Buy
4,076
+241
+6% +$217K 0.33% 84
2024
Q2
$3.47M Buy
3,835
+33
+0.9% +$26.4K 0.33% 80
2024
Q1
$2.07M Buy
3,802
+141
+4% +$100K 0.22% 102
2023
Q4
$2.13M Buy
+3,661
New +$2.14M 0.21% 101

Other funds holding LLY

TritonPoint Wealth's LLY Position: Q2 2026 in Review

TritonPoint Wealth increased its Eli Lilly (LLY) stake by 3.7% in Q2 2026, buying an estimated $136K and bringing the position to 3,728 shares worth $4.47M. The position accounts for 0.44% of the portfolio, ranked #56.

TritonPoint Wealth first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TritonPoint Wealth held 3,728 shares of Eli Lilly worth $4.47M as of Q2 2026.
  • TritonPoint Wealth bought 133 Eli Lilly shares in Q2 2026, an estimated $136K.
  • Eli Lilly made up 0.44% of TritonPoint Wealth's portfolio in Q2 2026, its #56 holding.
  • TritonPoint Wealth first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TritonPoint Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.